Pathogenesis of lentivirus infections (Q38164170)

30 August 2017

1 reference

title

Pathogenesis of lentivirus infections (English)

1 reference

30 August 2017

0 references

Haase AT

1

1 reference

30 August 2017

language of work or name

English

0 references

publication date

1 July 1986

1 reference

30 August 2017

1 reference

30 August 2017

volume

322

1 reference

30 August 2017

issue

6075

1 reference

30 August 2017

page(s)

130-136

1 reference

Visna, a demyelinating transmissible disease of sheep

30 August 2017

cites work

1 reference

Early Immune Responses in Visna, a Slow Viral Disease of Sheep

21 January 2018

1 reference

Correlation of transient accumulation of linear unintegrated viral DNA and transient cell killing by avian leukosis and reticuloendotheliosis viruses

21 January 2018

1 reference

Slow Virus Infection: Replication and Mechanisms of Persistence of Visna Virus in Sheep

21 January 2018

1 reference

Infection by the retrovirus associated with the acquired immunodeficiency syndrome. Clinical, biological, and molecular features

21 January 2018

1 reference

Resistance of Visna Virus to Interferon

21 January 2018

1 reference

Experimental visna in Icelandic sheep: the prototype lentiviral infection

21 January 2018

1 reference

7 January 2021

Human T-lymphotropic retroviruses

1 reference

7 January 2021

The ultrastructure of early visna lesions

1 reference

7 January 2021

Primary demyelination in visna. An ultrastructural study of Icelandic sheep with clinical signs following experimental infection

1 reference

7 January 2021

Unconventional Viruses and the Origin and Disappearance of Kuru

1 reference

7 January 2021

Slow Persistent Infection Caused by Visna Virus: Role of Host Restriction

1 reference

7 January 2021

The growth cycle of visna virus in monolayer cultures of sheep cells

1 reference

7 January 2021

Demonstration of a DNA provirus in the lytic growth of visna virus

1 reference

7 January 2021

Infectivity of visna virus DNA

1 reference

7 January 2021

Cell-fusing activity of visna virus particles

1 reference

7 January 2021

Gene expression in visna virus infection in sheep

1 reference

7 January 2021

Combined macroscopic and microscopic detection of viral genes in tissues

1 reference

7 January 2021

Slow virus visna: reproduction in vitro of virus from extrachromosomal DNA

1 reference

7 January 2021

A Trojan Horse mechanism for the spread of visna virus in monocytes

1 reference

7 January 2021

Slow Virus Replication: the Role of Macrophages in the Persistence and Expression of Visna Viruses of Sheep and Goats

1 reference

7 January 2021

Persistent noncytopathic infection of normal human T lymphocytes with AIDS-associated retrovirus

1 reference

7 January 2021

Induction of HTLV-III/LAV from a nonvirus-producing T-cell line: implications for latency

1 reference

7 January 2021

The epidemiology of AIDS: current status and future prospects

1 reference

7 January 2021

Lentiviruses are naturally resident in a latent form in long-term ovine fibroblast cultures

1 reference

7 January 2021

Circles with two tandem LTRs are precursors to integrated retrovirus DNA.

1 reference

7 January 2021

Visna virus DNA: Discovery of a novel gapped structure

1 reference

7 January 2021

Molecular Characterization of Human T-Cell Leukemia (Lymphotropic) Virus Type III in the Acquired Immune Deficiency Syndrome

1 reference

7 January 2021

Molecular cloning of integrated caprine arthritis-encephalitis virus

1 reference

7 January 2021

Antigenic variation in visna virus

1 reference

7 January 2021

Antigenic Shift of Visna Virus in Persistently Infected Sheep

1 reference

7 January 2021

Genomic changes associated with antigenic variation of visna virus durig persistent infection

1 reference

7 January 2021

Antigenic Drift in Visna: Virus Variation During Long-term Infection of Icelandic Sheep

1 reference

7 January 2021

The Emergence of Antigenic Variants is a Rare Event in Long-term Visna Virus Infection in vivo

1 reference

7 January 2021

Genomic diversity of human T-lymphotropic virus type III (HTLV-III).

1 reference

7 January 2021

Genomic diversity of the acquired immune deficiency syndrome virus HTLV-III: different viruses exhibit greatest divergence in their envelope genes

1 reference

7 January 2021

Detection of visna virus antigens and RNA in glial cells in foci of demyelination

1 reference

7 January 2021

Simultaneous in situ detection of viral RNA and antigens

1 reference

7 January 2021

Chronic Arthritis in Goats Caused by a Retrovirus

1 reference

7 January 2021

A sequential study of virus expression in retrovirus-induced arthritis of goats

1 reference

7 January 2021

Human mononuclear cell factors mediate cartilage matrix degradation through chondrocyte activation

1 reference

7 January 2021

Associated focal and segmental glomerulosclerosis in the acquired immunodeficiency syndrome.

1 reference

7 January 2021

Acute AIDS retrovirus infection. Definition of a clinical illness associated with seroconversion

1 reference

7 January 2021

HTLV-III infection in brains of children and adults with AIDS encephalopathy

1 reference

7 January 2021

Progressive encephalopathy in children with acquired immune deficiency syndrome

1 reference

7 January 2021

Vacuolar myelopathy pathologically resembling subacute combined degeneration in patients with the acquired immunodeficiency syndrome

1 reference

7 January 2021

Retroviral spongiform polioencephalomyelopathy

1 reference

7 January 2021

AIDS — An Immunologic Reevaluation

1 reference

7 January 2021

Lack of neutralizing antibodies to caprine arthritis-encephalitis lentivirus in persistently infected goats can be overcome by immunization with inactivated Mycobacterium tuberculosis

1 reference

7 January 2021

The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus

1 reference

7 January 2021

T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV

1 reference

7 January 2021

Detection of lymphocytes expressing human T-lymphotropic virus type III in lymph nodes and peripheral blood from infected individuals by in situ hybridization

1 reference

7 January 2021

Lymphocyte-reactive antibodies in acquired immune deficiency syndrome

1 reference

7 January 2021

Approaches to AIDS therapy

1 reference

7 January 2021

Influence of the human T-lymphotropic virus/lymphadenopathy-associated virus on functions of human lymphocytes: evidence for immunosuppressive effects and polyclonal B-cell activation by banded viral preparations

1 reference

7 January 2021

Abrogation of lymphocyte blastogenesis by a feline leukaemia virus protein

1 reference

7 January 2021

Slim disease: a new disease in Uganda and its association with HTLV-III infection.

1 reference

7 January 2021

A macrophage factor inhibits adipocyte gene expression: an in vitro model of cachexia

1 reference

7 January 2021

Visna DNA synthesis and the tempo of infection in vitro

1 reference

7 January 2021

Neutralizing antibody spectrum determines the antigenic profiles of emerging mutants of visna virus

1 reference

7 January 2021

Quantitative analysis of visna virus replication in vivo

1 reference

7 January 2021

Sera and cerebrospinal fluids from normal uninfected sheep contain a visna virus inhibiting factor

1 reference

7 January 2021

Maedi-visna control in sheep II. Half-yearly serological testing with culling of positive ewes and progeny

1 reference

7 January 2021

HTLV-III-neutralizing antibodies in patients with AIDS and AIDS-related complex

1 reference

7 January 2021

Neutralization of human T-lymphotropic virus type III by sera of AIDS and AIDS-risk patients

1 reference

7 January 2021

HTLV-III in Cells Cultured from Semen of Two Patients with AIDS

1 reference

7 January 2021

HTLV-III in saliva of people with AIDS-related complex and healthy homosexual men at risk for AIDS.

1 reference

7 January 2021

Isolation of HTLV-III from cerebrospinal fluid and neural tissues of patients with neurologic syndromes related to the acquired immunodeficiency syndrome

1 reference

7 January 2021

Intra-blood-brain-barrier synthesis of HTLV-III-specific IgG in patients with neurologic symptoms associated with AIDS or AIDS-related complex

1 reference

7 January 2021

Inhibition of RNA slow viruses by thiosemicarbazones

1 reference

7 January 2021

Phosphonoformate inhibition of visna virus replication

1 reference

7 January 2021

Restricted replication of lentiviruses. Visna viruses induce a unique interferon during interaction between lymphocytes and infected macrophages

1 reference

7 January 2021

Effects of suramin on HTLV-III/LAV infection presenting as Kaposi's sarcoma or AIDS-related complex: clinical pharmacology and suppression of virus replication in vivo

1 reference

7 January 2021

3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro

1 reference

7 January 2021

Trans-acting transcriptional regulation of human T-cell leukemia virus type III long terminal repeat

1 reference

7 January 2021

The location of cis-acting regulatory sequences in the human T cell lymphotropic virus type III (HTLV-III/LAV) long terminal repeat

1 reference

7 January 2021

Trans-activator gene of human T-lymphotropic virus type III (HTLV-III).

1 reference

7 January 2021

Post-transcriptional regulation accounts for the trans-activation of the human T-lymphotropic virus type III.

1 reference

7 January 2021

The trans-activator gene of the human T cell lymphotropic virus type III is required for replication

1 reference

7 January 2021

The trans-activator gene of HTLV-III is essential for virus replication

1 reference

7 January 2021

cis- and trans-acting transcriptional regulation of visna virus

1 reference

7 January 2021

Nucleotide sequence of the visna lentivirus: relationship to the AIDS virus

1 reference

7 January 2021

Nucleotide sequence and expression of an AIDS-associated retrovirus (ARV-2).

1 reference

7 January 2021

Complete nucleotide sequence of the AIDS virus, HTLV-III

1 reference

7 January 2021

Nucleic acid structure and expression of the human AIDS/lymphadenopathy retrovirus

1 reference

7 January 2021

Nucleotide sequence of the AIDS virus, LAV

1 reference

7 January 2021

Replicative and cytopathic potential of HTLV-III/LAV with sor gene deletions

1 reference

7 January 2021

Long-term cultures of HTLV-III--infected T cells: a model of cytopathology of T-cell depletion in AIDS.

1 reference

7 January 2021

Constitutive and conditional suppression of exogenous and endogenous genes by anti-sense RNA.

1 reference

7 January 2021

A novel immune system against bacteriophage infection using complementary RNA (micRNA).

1 reference

7 January 2021

Anti-mRNA: specific inhibition of translation of single mRNA molecules

1 reference

7 January 2021

The AIDS lentivirus connection

1 reference

7 January 2021

Sequence homology and morphologic similarity of HTLV-III and visna virus, a pathogenic lentivirus

1 reference

7 January 2021

Caprine arthritis-encephalitis virus is distinct from visna and progressive pneumonia viruses as measured by genome sequence homology

1 reference

7 January 2021

Antigenic cross-reactivity between caprine arthritis-encephalitis, visna and progressive pneumonia viruses involves all virion-associated proteins and glycoproteins

1 reference

7 January 2021

Nucleotide sequence evidence for relationship of AIDS retrovirus to lentiviruses

1 reference

7 January 2021

Electron microscopic studies on equine infectious anemia virus (EIAV)

1 reference

7 January 2021

Equine infectious anemia virus gag and pol genes: relatedness to visna and AIDS virus

1 reference

7 January 2021

Identification and antigenicity of the major envelope glycoprotein of lymphadenopathy-associated virus

1 reference

7 January 2021

Virus envelope protein of HTLV-III represents major target antigen for antibodies in AIDS patients

1 reference

7 January 2021

Identifiers

DOI

10.1038/322130A0

1 reference

30 August 2017

1 reference